40 episodes

The Brom Podcast covers the emerging psychedelics industry from a business, investing, cultural and social impact perspective. Episodes feature psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.

Brom Rector is the founder and general partner of Empath Ventures, a venture capital fund that invests in early stage startups focused on psychedelic medicine.

Brom Podcast Brom Rector and Empath Ventures

    • Technology
    • 5.0 • 4 Ratings

The Brom Podcast covers the emerging psychedelics industry from a business, investing, cultural and social impact perspective. Episodes feature psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.

Brom Rector is the founder and general partner of Empath Ventures, a venture capital fund that invests in early stage startups focused on psychedelic medicine.

    39: Psychedelics, Connection and Sex with Dr. Molly Maloof

    39: Psychedelics, Connection and Sex with Dr. Molly Maloof

    Lack of authentic human connection is one of the biggest problems facing society.  Can psychedelics deepen our relationships, strengthen our communities and help us have better sex?  Dr Molly thinks that the answer just might be "Yes".   

    In this episode: 

    - battling the stigmas around sex and drugs 

    - how psychedelics can improve your sex life 

    - the risks of falling in love with an AI boy/girl friend    



    Follow Dr Molly at https://drmolly.co/ 

    Check out Brom's VC fund at https://www.empath.vc



    Make sure to subscribe to the show!

    • 1 hr 22 min
    38: Selling Psilocybin Mushrooms Online with the Founder of Schedule35

    38: Selling Psilocybin Mushrooms Online with the Founder of Schedule35

    Schedule35 sells psilocybin mushrooms online in the US and Canada (yep, you heard that right).  Their branding is amazing and they advertise on mainstream podcasts like Hotboxin' with Mike Tyson - where I first heard of them.

    Leon, the founder of Schedule35 joins Brom today to tell us:



    - how he got into microdosing and started Schedule35 

    - what it takes to run an online psilocybin business in the current regulatory environment 

    - his views on pharma / medicalized psychedelics VS recreational psychedelics 



    Make sure to subscribe to the show! 

    Check out Schedule35 at schedule35.co

    Check out Brom's VC fund at empath.vc

    • 41 min
    The Brom Podcast - Psychedelics from an Investing, Scientific, Cultural & Social Impact Perspective

    The Brom Podcast - Psychedelics from an Investing, Scientific, Cultural & Social Impact Perspective

    The Brom Podcast covers the emerging psychedelics industry from a business, investing and social impact perspective.    

    Episodes feature Empath Ventures' Founder, Brom Rector interviewing psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.  

    The Brom Podcast is available on all platforms!



    Music from Uppbeat (free for Creators!): 

    https://uppbeat.io/t/sky-toes/desert-flower

    License code: JIRV6GGWC28YEPJH

    • 2 min
    37: Rebecca Nicholson - Investing in Psychedelic Retreats, Tripping with Amanda Feilding and the Importance of Female Representation in Psychedelics

    37: Rebecca Nicholson - Investing in Psychedelic Retreats, Tripping with Amanda Feilding and the Importance of Female Representation in Psychedelics

    Rebecca Nicholson is the CEO of 5D World and Founding partner of 5D Ventures.  Unlike other psychedelic VCs that focus on biotech, 5D’s “Progression of Consciousness Fund” is the only psychedelic fund focused on investing in psychedelic retreats.  Rebecca joins the Brom podcast to discuss:   



    - her views on investing in retreats 

    - the difference between retreats and clinics 

    - her own experience at some of these retreats - including tripping with Amanda Feilding 

    - the importance of the feminine perspective in the psychedelic industry.



    Make sure to subscribe to the show!  



    Check out 5d world at: https://www.5dworld.com/

    Follow Brom on Twitter:  https://www.twitter.com/therealbrom

    Brom's Venture Fund:  https://www.empath.vc

    • 1 hr 3 min
    36: Zach Haigney, Author of The Trip Report - Future Trends in the Psychedelics Industry

    36: Zach Haigney, Author of The Trip Report - Future Trends in the Psychedelics Industry

    Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape.  In this conversation, Zach and Brom discuss emerging trends, questions and hot topics in the psychedelics industry including:  


    The lines of tension between Drug Development and Drug Policy
    Directive vs Non-Directive Psychedelic Therapy 
    How Psychedelics are inverting the traditional drug development model 
    What business models will emerge in psychedelics? 
    Are fears about VC investment in psychedelics overstated?  
    How psychedelics can be thought of as a form of hormetic therapy 
    What can psychedelics be used for outside of treating mental health issues?  



    We also discuss The Trip Report's recent acquisition by Beckley Waves.  

    You can check out The Trip Report here:  https://thetripreport.substack.com/ 

    Follow Zach on Twitter: https://twitter.com/zach_haigney

    Follow Brom on Twitter:  https://twitter.com/therealbrom 



    Make sure to subscribe to the show!

    • 58 min
    35: Sam Banister - The Art and Science of Designing Novel Psychedelic Compounds

    35: Sam Banister - The Art and Science of Designing Novel Psychedelic Compounds

    Sam Banister is a medicinal chemist and co-founder of Psylo.  Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness.   



    Sam is here to help us understand how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made,  and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.  



    Make sure to subscribe to the show!  



    Follow Brom on twitter: https://twitter.com/therealbrom

    Follow Sam on twitter: https://twitter.com/samuel_b_phd

    Brom's VC Fund:  https://www.empath.vc

    Highlighted Timestamps:  

    06:12 - Are next generation psychedelics taking over in 10 years?  

    16:10 - What is the process like for creating a new chemical entities?  

    50:39 - Psychedelics vs Cannabis: New drug discoveries

    • 1 hr 1 min

Customer Reviews

5.0 out of 5
4 Ratings

4 Ratings

Emery Goossens ,

Professional Analysis, Novel Content

brom provides an insiders view into an up and coming industry with amazing interviews and detailed company analyses. Topics can be quite complex, but he covers them in an approachable way. I’m always excited to see new content from this guy!

You Might Also Like

Psychedelics Today
MAPS
Paul Austin
Mark Plotkin, Ph.D.
Hamilton Morris
Bill Maher